Acute Gout Treatment Guidelines

Introduction to Treatment Options

The American College of Physicians recommends that prednisone should be considered first-line therapy in patients with acute gout without contraindications because it is safer, lower cost, and has fewer adverse effects 1

High-quality evidence demonstrates that corticosteroids, NSAIDs, and colchicine are all effective treatments to reduce pain in patients with acute gout, with no significant difference in efficacy between these options 1
Low-dose colchicine achieves treatment success in approximately 42% of patients compared to 17% with placebo, with an absolute improvement of 25% 2
Oral prednisone at 35 mg for 5 days has been successfully used to treat acute gout with Level A evidence supporting its equivalency to NSAIDs 1, 3

The European League Against Rheumatism recommends prednisolone 30-35 mg daily for 3-5 days as first-line treatment 2, 3
Administer 1.2 mg of colchicine at first sign of flare followed by 0.6 mg one hour later, then continue 0.6 mg once or twice daily until attack resolves 2

Systemic fungal infections are an absolute contraindication for prednisone 1, 3
Severe renal impairment is a contraindication for colchicine 2
Concurrent use of strong CYP3A4 inhibitors or P-glycoprotein inhibitors is an absolute contraindication for colchicine 2

If no contraindications to corticosteroids, use prednisone 30-35 mg daily for 5 days 1, 3
If corticosteroids are contraindicated but colchicine is safe, use low-dose colchicine regimen 2
In patients with renal disease, heart failure, or cirrhosis, strongly favor prednisone over colchicine or NSAIDs 1, 3

For severe attacks involving multiple large joints, consider combination therapy with colchicine and prednisone for synergistic anti-inflammatory effects 2

Intra-articular corticosteroid injection is an effective and safe alternative option for patients with a single joint affected, according to the European League Against Rheumatism 4, 5
Low-dose colchicine (1.2 mg initially, then 0.6 mg one hour later) may be used if renal function is adequate, but monitor closely, as recommended by the American College of Rheumatology 6
The American College of Rheumatology recommends that high-dose colchicine regimens (hourly dosing) be abandoned due to excessive toxicity 4, 7
Full anti-inflammatory doses of any NSAID are effective, with naproxen, indomethacin, and sulindac having FDA approval for acute gout, according to the American College of Rheumatology 7

The American College of Rheumatology recommends initiating pharmacologic therapy within 24 hours of acute attack onset for best outcomes, with early treatment leading to better patient-reported outcomes and shorter attack duration 7
Patient education should include self-initiation of treatment at first symptoms without waiting for physician consultation, as recommended by the American College of Rheumatology 7

The American College of Rheumatology suggests that severe polyarticular attacks involving multiple large joints with pain >6/10 may benefit from combining colchicine with prednisone for synergistic anti-inflammatory effects 7